Pathophysiology and therapy for allergic and nonallergic rhinitis: An updated review

T. Levenson*, Paul Allen Greenberger, Ernest S. Bazley

*Corresponding author for this work

Research output: Contribution to journalArticlepeer-review


Symptoms from rhinitis can be assessed to be more troubling to trie patient than symptoms from asthma. Further, the array of bioactivc mediators, cytokines, and cells in nasal mucosa suggests that rhinitis is a much more complex condition than formerly thought. The presence of allergic rhinitis is a risk factor for emergence of asthma. Topical nasal corticosteroids have a relatively flat dose-response curve and have onset of action within one to two days for some patients. Allergen immunotherapy remains the only immunomodulator for patients with allergic rhinitis, with the possible exception of long-term administration of nasal corticosteroids, Author.

Original languageEnglish (US)
Number of pages1
JournalJournal of Laryngology and Otology
Issue number1
StatePublished - Dec 1 1998

ASJC Scopus subject areas

  • Otorhinolaryngology

Fingerprint Dive into the research topics of 'Pathophysiology and therapy for allergic and nonallergic rhinitis: An updated review'. Together they form a unique fingerprint.

Cite this